Publications:

---

Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening.

Cancers

Suda, Kenichi K; Sakai, Kazuko K; Ohira, Tatsuo T; Chikugo, Takaaki T; Satou, Takao T; Matsubayashi, Jun J; Nagao, Toshitaka T; Ikeda, Norihiko N; Tsutani, Yasuhiro Y; Mitsudomi, Tetsuya T; Nishio, Kazuto K

Publication Date: 2023-05-07

Variant appearance in text: EGFR: L747P

PubMed Link: 37174112

Variant Present in the following documents:

• Main text
• cancers-15-02648.pdf

View BVdb publication page

---

Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma.

Frontiers In Oncology

Cao, Ran R; Chen, Huanhuan H; Wang, Huan H; Wang, Yan Y; Cui, E-Nuo EN; Jiang, Wenyan W

Publication Date: 2023

Variant appearance in text: EGFR: L747P

PubMed Link: 37143947

Variant Present in the following documents:

• fonc-13-1154327.pdf

View BVdb publication page

---

Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.

The Oncologist

Wang, Chunsheng C; Zhao, Kewei K; Hu, Shanliang S; Dong, Wei W; Gong, Yan Y; Xie, Conghua C

Publication Date: 2023-04-28

Variant appearance in text: EGFR: L747P

PubMed Link: 37116899

Variant Present in the following documents:

• Main text
• oyad111.pdf

View BVdb publication page

---

Genomics-Driven Precision Medicine in Pediatric Solid Tumors.

Cancers

Suthapot, Praewa P; Chiangjong, Wararat W; Chaiyawat, Parunya P; Choochuen, Pongsakorn P; Pruksakorn, Dumnoensun D; Sangkhathat, Surasak S; Hongeng, Suradej S; Anurathapan, Usanarat U; Chutipongtanate, Somchai S

Publication Date: 2023-02-23

Variant appearance in text: EGFR: L747P

PubMed Link: 36900212

Variant Present in the following documents:

• Main text
• cancers-15-01418.pdf

View BVdb publication page

---

Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.

Jto Clinical And Research Reports

Ji, Jingran J; Aredo, Jacqueline V JV; Piper-Vallillo, Andrew A; Huppert, Laura L; Rotow, Julia K JK; Husain, Hatim H; Stewart, Susan S; Cobb, Rosemary R; Wakelee, Heather A HA; Blakely, Collin M CM; Wong, Melisa L ML; Gubens, Matthew A MA; Madani, Mohammad H MH; Digumarthy, Subba R SR; McCoach, Caroline C; Piotrowska, Zofia Z; Neal, Joel W JW; Riess, Jonathan W JW

Publication Date: 2023-03

Variant appearance in text: EGFR: L747P

PubMed Link: 36879929

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery

Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI

Publication Date: 2023-03-02

Variant appearance in text: EGFR: 2239_2240delinsCC; L747P; rs397517096

PubMed Link: 36862804

Variant Present in the following documents:

• cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6

View BVdb publication page

---

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer.

Frontiers In Genetics

G, Vigneshwaran V; Hasan, Qurratulain Annie QA; Kumar, Rahul R; Eranki, Avinash A

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 36561320

Variant Present in the following documents:

• Table3.xlsx, sheet 1
• Table2.xlsx, sheet 4

View BVdb publication page

---

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: EGFR: 2239_2240delTTinsCC; L747P

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 3
• Table_2.xlsx, sheet 2

View BVdb publication page

---

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Frontiers In Oncology

Dong, Wei W; Wang, Congjie C; Wang, Chunsheng C; Zhao, Kewei K; Ma, Zhao Z; Hu, Shanliang S

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 36425553

Variant Present in the following documents:

• Main text
• DataSheet_1.pdf
• fonc-12-999606.pdf

View BVdb publication page

---

Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients - an overview.

Frontiers In Oncology

Van De Stadt, Eveline E; Yaqub, Maqsood M; Jahangir, A A AA; Hendrikse, Harry H; Bahce, Idris I

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 36313723

Variant Present in the following documents:

• Main text
• fonc-12-900450.pdf

View BVdb publication page

---

Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis.

Oncology Letters

Lan, Bo B; Zhao, Na N; Du, Kang K; Leng, Baolang B

Publication Date: 2022-11

Variant appearance in text: EGFR: L747P

PubMed Link: 36238360

Variant Present in the following documents:

• ol-24-05-13504.pdf

View BVdb publication page

---

Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.

Thoracic Cancer

Kanbe, Mio M; Sunaga, Noriaki N; Hara, Kenichiro K; Sawada, Hiiru H; Wakamatsu, Ikuo I; Hara, Kentaro K; Muto, Sohei S; Sawada, Yuri Y; Masubuchi, Hiroaki H; Sato, Mari M; Miura, Yosuke Y; Tsurumaki, Hiroaki H; Yatomi, Masakiyo M; Sakurai, Reiko R; Koga, Yasuhiko Y; Ohtaki, Yoichi Y; Nagashima, Toshiteru T; Okano, Naoko N; Kubo, Nobuteru N; Maeno, Toshitaka T; Hisada, Takeshi T

Publication Date: 2022-11

Variant appearance in text: EGFR: L747P

PubMed Link: 36193787

Variant Present in the following documents:

• Main text
• TCA-13-3225.pdf

View BVdb publication page

---

Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer

Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X

Publication Date: 2022-09-27

Variant appearance in text: EGFR: L747P

PubMed Link: 36167530

Variant Present in the following documents:

• 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

---

Insensitivity to T790M mutation? A pooled analysis of outcomes following osimertinib for the treatment of NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Frontiers In Pharmacology

Hu, Shanliang S; Wang, Congjie C; Wang, Chunsheng C; Zhao, Kewei K; Wang, Zhen Z; Dong, Wei W

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 36091840

Variant Present in the following documents:

• Main text
• fphar-13-986962.pdf

View BVdb publication page

---

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.

Nature Cancer

Vanguri, Rami S RS; Luo, Jia J; Aukerman, Andrew T AT; Egger, Jacklynn V JV; Fong, Christopher J CJ; Horvat, Natally N; Pagano, Andrew A; Araujo-Filho, Jose de Arimateia Batista JAB; Geneslaw, Luke L; Rizvi, Hira H; Sosa, Ramon R; Boehm, Kevin M KM; Yang, Soo-Ryum SR; Bodd, Francis M FM; Ventura, Katia K; Hollmann, Travis J TJ; Ginsberg, Michelle S MS; Gao, Jianjiong J; , ; Hellmann, Matthew D MD; Sauter, Jennifer L JL; Shah, Sohrab P SP

Publication Date: 2022-10

Variant appearance in text: EGFR: L747P

PubMed Link: 36038778

Variant Present in the following documents:

• 43018_2022_416_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.

Frontiers In Oncology

Yin, Xiang-Qian XQ; Yin, Xue-Hui XH; Yu, Ya-Qin YQ; Xu, Lang L; Zhang, Mao M

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 35936718

Variant Present in the following documents:

• Table_4.xlsx, sheet 2

View BVdb publication page

---

Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc

White, Valerie A VA; Hyrcza, Martin D MD; Lennerz, Jochen K JK; Thierauf, Julia J; Lokuhetty, Dilani D; Cree, Ian A IA; Indave, Blanca Iciar BI

Publication Date: 2022-10

Variant appearance in text: EGFR: L747P

PubMed Link: 35871081

Variant Present in the following documents:

• 41379_2022_1100_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

---

Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Frontiers In Oncology

Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J

Publication Date: 2022

Variant appearance in text: EGFR: 2239_2240delTTinsCC; L747P

PubMed Link: 35814426

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 2

View BVdb publication page

---

Rapid Determination of 9 Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma in Human Plasma by QuEChERS-UPLC-MS/MS.

Frontiers In Pharmacology

Jiang, Wen W; Zhao, Tingting T; Zhen, Xiaolan X; Jin, Chengcheng C; Li, Hui H; Ha, Jing J

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 35800447

Variant Present in the following documents:

• fphar-13-920436.pdf

View BVdb publication page

---

Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases.

Frontiers In Oncology

Zhang, Lili L; Yang, Lu L; Sun, Binxu B; Deng, Yixiao Y; Yang, Jie J; Wu, Dongfang D; Kong, Fanming F

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 35712479

Variant Present in the following documents:

• Main text
• fonc-12-861271.pdf

View BVdb publication page

---

TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report.

Jto Clinical And Research Reports

Kunimasa, Kei K; Hirotsu, Yosuke Y; Amemiya, Kenji K; Nakamura, Harumi H; Nishino, Kazumi K; Honma, Keiichiro K; Okami, Jiro J; Omata, Masao M; Kumagai, Toru T

Publication Date: 2022-05

Variant appearance in text: rs397517096

PubMed Link: 35498386

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

---

Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.

Oncogene

Ikeuchi, Hiroshi H; Hirose, Takeshi T; Ikegami, Masachika M; Takamochi, Kazuya K; Suzuki, Kenji K; Mano, Hiroyuki H; Kohsaka, Shinji S

Publication Date: 2022-04

Variant appearance in text: EGFR: L747P

PubMed Link: 35304574

Variant Present in the following documents:

• 41388_2022_Article_2263.pdf

View BVdb publication page

---

Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications

Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L

Publication Date: 2022-03-10

Variant appearance in text: EGFR: 2239_2240delTTinsCC; L747P

PubMed Link: 35273153

Variant Present in the following documents:

• 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors.

Frontiers In Oncology

Yang, Guangjian G; Liu, Chengming C; Hu, Jiaqi J; Sun, Yang Y; Hu, Peizeng P; Liu, Liu L; Xu, Haiyan H; Li, Dazhou D; Li, Weihua W; Yang, Yaning Y; Sun, Nan N; He, Jie J; Wang, Yan Y

Publication Date: 2022

Variant appearance in text: EGFR: L747P

PubMed Link: 35223527

Variant Present in the following documents:

• Main text
• fonc-12-843299.pdf
• DataSheet_1.pdf

View BVdb publication page

---

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer

Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J

Publication Date: 2022-02

Variant appearance in text: EGFR: Leu747Pro

PubMed Link: 35221333

Variant Present in the following documents:

• 43018_2022_332_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.

Scientific Reports

Sitthideatphaiboon, Piyada P; Teerapakpinyo, Chinachote C; Korphaisarn, Krittiya K; Leelayuwatanakul, Nophol N; Pornpatrananrak, Nopporn N; Poungvarin, Naravat N; Chantranuwat, Poonchavist P; Shuangshoti, Shanop S; Aporntewan, Chatchawit C; Chintanapakdee, Wariya W; Sriuranpong, Virote V; Vinayanuwattikun, Chanida C

Publication Date: 2022-02-09

Variant appearance in text: EGFR: L747P

PubMed Link: 35140316

Variant Present in the following documents:

• 41598_2022_6239_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

---

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.

Scientific Reports

Sitthideatphaiboon, Piyada P; Teerapakpinyo, Chinachote C; Korphaisarn, Krittiya K; Leelayuwatanakul, Nophol N; Pornpatrananrak, Nopporn N; Poungvarin, Naravat N; Chantranuwat, Poonchavist P; Shuangshoti, Shanop S; Aporntewan, Chatchawit C; Chintanapakdee, Wariya W; Sriuranpong, Virote V; Vinayanuwattikun, Chanida C

Publication Date: 2022-02-09

Variant appearance in text: EGFR: L747P

PubMed Link: 35140316

Variant Present in the following documents:

• 41598_2022_6239_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

---

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.

Frontiers In Oncology

Zhang, Jiexia J; Tang, Shuangfeng S; Zhang, Chunning C; Li, Mingyao M; Zheng, Yating Y; Hu, Xue X; Huang, Mengli M; Cheng, Xiangyang X

Publication Date: 2021

Variant appearance in text: EGFR: 2239_2240delinsCC; L747P

PubMed Link: 35087742

Variant Present in the following documents:

• Table_2.xlsx, sheet 1

View BVdb publication page

---

EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma.

Cancers

Pacini, Laura L; Cabal, Virginia N VN; Hermsen, Mario A MA; Huang, Paul H PH

Publication Date: 2022-01-13

Variant appearance in text: EGFR: L747P

PubMed Link: 35053553

Variant Present in the following documents:

• Main text

View BVdb publication page

---

EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma.

Cancers

Pacini, Laura L; Cabal, Virginia N VN; Hermsen, Mario A MA; Huang, Paul H PH

Publication Date: 2022-01-13

Variant appearance in text: EGFR: L747P

PubMed Link: 35053553

Variant Present in the following documents:

• Main text

View BVdb publication page

---

A real-world study of dacomitinib in later-line settings for advanced non-small cell lung cancer patients harboring EGFR mutations.

Cancer Medicine

Li, Hong-Shuai HS; Zhang, Jin-Yao JY; Yan, Xiang X; Xu, Hai-Yan HY; Hao, Xue-Zhi XZ; Xing, Pu-Yuan PY; Wang, Yan Y

Publication Date: 2022-02

Variant appearance in text: EGFR: L747P

PubMed Link: 35023313

Variant Present in the following documents:

• Main text
• CAM4-11-1026.pdf

View BVdb publication page

---

Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy.

Frontiers In Oncology

Liu, Jie J; Xu, Wang-Yang WY; Ye, Maosong M; Liu, Zilong Z; Li, Chun C

Publication Date: 2021

Variant appearance in text: EGFR: L747P

PubMed Link: 34970478

Variant Present in the following documents:

• Main text
• fonc-11-726547.pdf

View BVdb publication page

---

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.

Bmc Cancer

Wang, Yurong Y; Zheng, Ruipan R; Hu, Peizhu P; Zhang, Ziheng Z; Shen, Shujing S; Li, Xingya X

Publication Date: 2021-11-13

Variant appearance in text: EGFR: L747P

PubMed Link: 34774017

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin.

Scientific Reports

Chinnappan, Jayaprakash J; Ramu, Akilandeswari A; V, Vidhya Rajalakshmi VR; S, Akil Kavya AK

Publication Date: 2021-11-11

Variant appearance in text: EGFR: L747P

PubMed Link: 34764329

Variant Present in the following documents:

• Main text
• 41598_2021_Article_1508.pdf

View BVdb publication page

---

Genomic alterations in tumor tissue and ctDNA from Chinese pancreatic cancer patients.

American Journal Of Cancer Research

Xiong, Anwen A; Ma, Ning N; Wei, Guo G; Li, Chunhua C; Li, Kainan K; Wang, Bin B

Publication Date: 2021

Variant appearance in text: EGFR: L747P

PubMed Link: 34659905

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models.

Evidence-Based Complementary And Alternative Medicine : Ecam

Yu, Ya-Ya YY; Zhu, Yan-Juan YJ; Zou, Ying Y; Xiao, Zhen-Zhen ZZ; Shi, Shuai S; Liu, Yi-Hong YH; Chang, Xue-Song XS; Chen, Ya-Dong YD; Zhang, Hai-Bo HB

Publication Date: 2021

Variant appearance in text: EGFR: L747P

PubMed Link: 34646330

Variant Present in the following documents:

• ECAM2021-9911935.pdf

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: EGFR: L747P

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Clinical Characteristics and Molecular Profiles of Lung Cancer in Ethiopia.

Jto Clinical And Research Reports

Gebremariam, Tewodros H TH; Haisch, Deborah A DA; Fernandes, Helen H; Huluka, Dawit K DK; Binegdie, Amsalu B AB; Woldegeorgis, Mathewos A MA; Ergetie, Wondwosen W; Worku, Aschalew A; Zerihun, Lillian M LM; Cohen, Matthew M; Massion, Pierre P PP; Sherman, Charles B CB; Saqi, Anjali A; Schluger, Neil W NW

Publication Date: 2021-07

Variant appearance in text: EGFR: L747P

PubMed Link: 34590041

Variant Present in the following documents:

• Main text

View BVdb publication page

---

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib.

Jto Clinical And Research Reports

Osoegawa, Atsushi A; Yamaguchi, Masafumi M; Nakamura, Tomomi T; Morinaga, Ryotaro R; Tanaka, Kentaro K; Kashiwabara, Kosuke K; Miura, Takashi T; Suetsugu, Takayuki T; Harada, Taishi T; Asoh, Tatsuma T; Taguchi, Kenichi K; Nabeshima, Kazuki K; Kishimoto, Junji J; Sakai, Kazuko K; Nishio, Kazuto K; Sugio, Kenji K

Publication Date: 2021-07

Variant appearance in text: rs397517096

PubMed Link: 34590037

Variant Present in the following documents:

• mmc1.xlsx, sheet 1
• mmc2.xlsx, sheet 1

View BVdb publication page

---

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations.

Thoracic Cancer

Li, Teng T; Wang, Shouzheng S; Ying, Jianming J; Wang, Yan Y; Hu, Xingsheng X; Hao, Xuezhi X; Xu, Ziyi Z; Xing, Puyuan P; Li, Junling J

Publication Date: 2021-11

Variant appearance in text: EGFR: L747P

PubMed Link: 34549528

Variant Present in the following documents:

• Main text
• TCA-12-2924.pdf

View BVdb publication page

---

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations.

Thoracic Cancer

Li, Teng T; Wang, Shouzheng S; Ying, Jianming J; Wang, Yan Y; Hu, Xingsheng X; Hao, Xuezhi X; Xu, Ziyi Z; Xing, Puyuan P; Li, Junling J

Publication Date: 2021-11

Variant appearance in text: EGFR: L747P

PubMed Link: 34549528

Variant Present in the following documents:

• Main text
• TCA-12-2924.pdf

View BVdb publication page

---

Structure-based classification predicts drug response in EGFR-mutant NSCLC.

Nature

Robichaux, Jacqulyne P JP; Le, Xiuning X; Vijayan, R S K RSK; Hicks, J Kevin JK; Heeke, Simon S; Elamin, Yasir Y YY; Lin, Heather Y HY; Udagawa, Hibiki H; Skoulidis, Ferdinandos F; Tran, Hai H; Varghese, Susan S; He, Junqin J; Zhang, Fahao F; Nilsson, Monique B MB; Hu, Lemei L; Poteete, Alissa A; Rinsurongkawong, Waree W; Zhang, Xiaoshan X; Ren, Chenghui C; Liu, Xiaoke X; Hong, Lingzhi L; Zhang, Jianjun J; Diao, Lixia L; Madison, Russell R; Schrock, Alexa B AB; Saam, Jennifer J; Raymond, Victoria V; Fang, Bingliang B; Wang, Jing J; Ha, Min Jin MJ; Cross, Jason B JB; Gray, Jhanelle E JE; Heymach, John V JV

Publication Date: 2021-09

Variant appearance in text: EGFR: L747P

PubMed Link: 34526717

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Proteome profiling of formalin-fixed, paraffin-embedded lung adenocarcinoma tissues using a tandem mass tag-based quantitative proteomics approach.

Oncology Letters

Xie, Qi Q; Wang, Dan D; Luo, Xiao X; Li, Zhen Z; Hu, Aixia A; Yang, Hui H; Tang, Jinxing J; Gao, Peiyu P; Sun, Tingyi T; Kong, Lingfei L

Publication Date: 2021-10

Variant appearance in text: EGFR: L747P

PubMed Link: 34457061

Variant Present in the following documents:

• Main text
• ol-22-04-12967.pdf

View BVdb publication page

---

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.

Cancers

Koopman, Bart B; Cajiao Garcia, Betzabel N BN; Kuijpers, Chantal C H J CCHJ; Damhuis, Ronald A M RAM; van der Wekken, Anthonie J AJ; Groen, Harry J M HJM; Schuuring, Ed E; Willems, Stefan M SM; van Kempen, Léon C LC

Publication Date: 2021-07-20

Variant appearance in text: EGFR: L747P

PubMed Link: 34298851

Variant Present in the following documents:

• Main text
• cancers-13-03641.pdf

View BVdb publication page

---

A Lung Adenocarcinoma Patient With a Rare EGFR E709_T710delinsD Mutation Showed a Good Response to Afatinib Treatment: A Case Report and Literature Review.

Frontiers In Oncology

Wei, Yu Y; Cui, Yueli Y; Guo, Yao Y; Li, Lei L; Zeng, Liang L

Publication Date: 2021

Variant appearance in text: EGFR: L747P

PubMed Link: 34178699

Variant Present in the following documents:

• Main text
• fonc-11-700345.pdf

View BVdb publication page

---